Cargando…
Preliminary stop of the TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC) trial
The “TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia” (TOPIC) trial was stopped preliminary, due to lagging inclusions. This study aimed to evaluate the treatment efficacy and clinical applicability of imiquimod 5% cream in high-grade cervical intraepithelial neoplasia (...
Autores principales: | Koeneman, M. M., Kruse, A. J., Kooreman, L. F. S., zur Hausen, A., Hopman, A. H. N., Sep, S. J. S., Van Gorp, T., Slangen, B. F. M., van Beekhuizen, H. J., van de Sande, A. J. M., Gerestein, C. G., Nijman, H. W., Kruitwagen, R. F. P. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297094/ https://www.ncbi.nlm.nih.gov/pubmed/28173776 http://dx.doi.org/10.1186/s12885-017-3108-9 |
Ejemplares similares
-
TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial
por: Koeneman, M. M., et al.
Publicado: (2016) -
Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter Study
por: Hendriks, Natasja, et al.
Publicado: (2022) -
TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial
por: van de Sande, A. J. M., et al.
Publicado: (2018) -
Systemic adverse events in imiquimod use for cervical intraepithelial neoplasia – A case series
por: Wouters, Tirza, et al.
Publicado: (2019) -
Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions
por: Abdulrahman, Ziena, et al.
Publicado: (2022)